| LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 |
1101 17th Street, NW
| Address2 |
Suite 500
|
| City |
Washington
| State |
DC
| Zip Code |
20036
| Country |
USA
|
3. Principal place of business (if different than line 2)
| City |
Yonkers
| State |
NY
| Zip Code |
10703
| Country |
USA
|
| 5. Senate ID# 10651-12
|
||||||||
| 6. House ID# 318070000
|
||||||||
| TYPE OF REPORT | 8. Year |
2008
| Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
| 11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income from the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
| Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature |
Digitally Signed By: Theresa Thomas, Office Administrator
| Date |
07/29/2008
|
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BAN
16. Specific lobbying issues
HR 5244, Credit Cardholders' Bill of Rights Act of 2008, issues related to credit card reform.
HR 3221, New Direction for Energy Independence, National Security, and Consumer Protection Act.
S 2908, Medicare Card Security Act of 2008.
Issues related to housing relief.
Issues related to identity theft and privacy.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Ellen
|
Bloom
|
|
| |
|
Jeannine
|
Kenney
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
S 2408, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007.
Issues related to product safety.
Issues related to mortgage legislation.
Issues related to credit card reform.
Issues related to hospital infections.
Issues related to drug safety.
Issues related to the safety of medical devices.
Issues related to e-prescribing.
Issues related to public disclosure of gifts to doctors.
Issues related to CPSC reform.
Issues related to food safety.
Issues related to lead limits in products.
Issues related to the consumer complaint public database at CPSC.
Issues related to auto safety.
Issues related to lead in ceramic dishware.
Issues related to fish inspection.
Issues related to food import safety.
Issues related to drug import safety.
Issues related to product recall reform.
Issues related to toy safety.
Issues related to toy testing and flamability standards.
Issues related to medical device and cosmetics safety.
Issues related to identity thefy.
Issues related to media ownership.
Issues related to DTV transition.
Issues related to cell phone early termination fees.
Issues related to the Cell Phone Consumer Empowerment Act.
Issues related to the Wireless Consumer Protection and Community Broadband Empowerment Act of 2007.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Natl Highway Traffic Safety Administration (NHTSA), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Ellen
|
Bloom
|
|
| |
|
Shannon
|
Baker-Branstetter
|
|
| |
|
Ami
|
Gadhia
|
|
| |
|
Jeannine
|
Kenney
|
|
| |
|
Eugene
|
Kimmelman
|
|
| |
|
Christopher
|
Murray
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Issues related to e-prescribing.
Issues related to medical device safety act.
Issues related to hospital infections.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Shannon
|
Baker-Branstetter
|
|
| |
|
Ellen
|
Bloom
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Issues and legislative policies related to food and drug safety.
Issues related to the FDA food protection plan.
Issues related to campylobacter regulations.
Issues related to the retail consignees rule.
Issues related to lead in ceramic dishware.
Issues related to FDA reform.
Issues related to food import safety.
Issues related fish inspections.
HR 2419, Farm Bill Extension Act of 2007.
Issues related to the FDA Globalization Act of 2008.
Issues related to recall disclosure.
Issues related to a moratorium on food from animal clones.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Ellen
|
Bloom
|
|
| |
|
Shannon
|
Baker-Branstetter
|
|
| |
|
Ami
|
Gadhia
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to e-prescribing and academic detailing.
Issues related to the Medical Device Safety Act.
Issues related to comprehensive effectiveness and medical privacy.
Issues relating to the drug import safety bill.
Issues related to hospital infections.
Issues related public disclosure of gifts to doctors.
HR 5605, Sunshine Physicians Payment Act 2008.
Issues related to the Direct to comsumer advertising of drugs and medical devices.
Issues related to drug import safety.
S 2408, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Shannon
|
Baker-Branstetter
|
|
| |
|
Ellen
|
Bloom
|
|
| |
|
Ami
|
Gadhia
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Issues related to drug safety.
Issues related to consumer advertising of medical and drug ads moratorium.
Issues related to the FDA Globalization Act of 2008.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Shannon
|
Baker-Branstetter
|
|
| |
|
Ellen
|
Bloom
|
|
| |
|
Ami
|
Gadhia
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TEC
16. Specific lobbying issues
Issues related to the XM/Sirius Merger.
Issues related to the DTV transition.
Issues relatied to the FCC cable regulation.
Issues related to broadcast cross-ownership prohibition.
S 2033, Cell Phone Consumer Empowerment Act.
Issues related to the Wireless Consumer Protection and Community Broadband Act of 2007.
Issues related to early termination penalties.
Issues related to Comcast BitTorrent.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Federal Communications Commission (FCC), Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Ellen
|
Bloom
|
|
| |
|
Christopeher
|
Murray
|
|
| |
|
Eugene
|
Kimmelman
|
|
| |
|
Joel
|
Kelsey
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
| State |
| Zip Code |
| Country |
|
21. Client new principal place of business (if different than line 20)
| City |
| State |
| Zip Code |
| Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
| 3 |
|
||||||
| 2 |
| 4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
|
||||||||||||||
|
|
|
|||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address | Principal place of business (city and state or country) | Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
|
||||||||||||||
|
|
| % | ||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |